Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Emerging Role of Neuron-Glia in Neurological Disorders: At a Glance.

Tytuł:
Emerging Role of Neuron-Glia in Neurological Disorders: At a Glance.
Autorzy:
Rahman MM; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Islam MR; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Yamin M; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Islam MM; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Sarker MT; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Meem AFK; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Akter A; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Emran TB; Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh.
Cavalu S; Faculty of Medicine and Pharmacy, University of Oradea, P-ta 1 Decembrie 10, 410087 Oradea, Romania.
Sharma R; Department of Rasa Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005 Uttar Pradesh, India.
Źródło:
Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2022 Aug 22; Vol. 2022, pp. 3201644. Date of Electronic Publication: 2022 Aug 22 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Publication: 2011- : New York : Hindawi Pub. Corp.
Original Publication: 2008-2010: Austin, TX : Landes Bioscience
MeSH Terms:
Nervous System Diseases*
Neuroglia*
Animals ; Central Nervous System ; Humans ; Neurogenesis ; Neurons/physiology
References:
Pharmacol Rev. 1998 Jun;50(2):291-313. (PMID: 9647870)
Brain Res. 1986 Jan 29;364(1):177-80. (PMID: 3004648)
CNS Neurosci Ther. 2013 Aug;19(8):549-55. (PMID: 23593992)
Trends Neurosci. 2008 Dec;31(12):653-9. (PMID: 18945498)
PLoS One. 2017 Nov 28;12(11):e0188524. (PMID: 29182653)
Bioinorg Chem Appl. 2022 Apr 29;2022:1685393. (PMID: 35529314)
Cell. 2012 Dec 21;151(7):1542-56. (PMID: 23260141)
Neurosci Lett. 1991 Jul 8;128(1):42-6. (PMID: 1717897)
Neuron. 2012 Oct 4;76(1):70-81. (PMID: 23040807)
Brain Res. 2004 Apr 23;1006(1):126-31. (PMID: 15047031)
Neurotherapeutics. 2010 Oct;7(4):439-51. (PMID: 20880507)
J Neurosci. 1997 Jun 15;17(12):4688-99. (PMID: 9169529)
Neuron. 2016 Sep 21;91(6):1199-1218. (PMID: 27657448)
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD007415. (PMID: 23633341)
Neural Regen Res. 2019 Dec;14(12):2043-2053. (PMID: 31397331)
J Neurochem. 2002 Feb;80(4):655-66. (PMID: 11841573)
Sci Rep. 2019 Sep 25;9(1):13855. (PMID: 31554841)
Int J Surg. 2022 Aug;104:106807. (PMID: 35922000)
Neuron. 2001 May;30(2):385-97. (PMID: 11395001)
Pharmacol Biochem Behav. 1990 Apr;35(4):955-62. (PMID: 2140610)
Mayo Clin Proc. 2005 Oct;80(10):1326-38. (PMID: 16212146)
Curr Opin Neurol. 2004 Jun;17(3):317-36. (PMID: 15167068)
Evid Based Complement Alternat Med. 2022 Apr 11;2022:6307529. (PMID: 35449824)
J Neurochem. 2015 Dec;135(6):1140-8. (PMID: 26390857)
Brain Res. 2007 Feb 2;1131(1):1-10. (PMID: 17182013)
Science. 2016 Feb 26;351(6276):933-9. (PMID: 26822608)
Nat Cell Biol. 2010 Jan;12(1):19-30; sup pp 1-13. (PMID: 19966785)
Mol Cell Neurosci. 2017 Mar;79:23-33. (PMID: 28064059)
Front Neurol. 2019 Mar 19;10:87. (PMID: 30941082)
Adv Exp Med Biol. 2019;1175:273-324. (PMID: 31583592)
Curr Opin Neurobiol. 2013 Dec;23(6):997-1004. (PMID: 23998929)
Neuron. 2008 Sep 25;59(6):932-46. (PMID: 18817732)
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14821-5. (PMID: 9405697)
Neurosci Lett. 2014 Apr 17;565:47-52. (PMID: 24184876)
Future Neurol. 2013 Mar 1;8(2):149-158. (PMID: 23658503)
Brain Res. 2001 Mar 9;894(1):131-40. (PMID: 11245823)
Nature. 2013 Feb 7;494(7435):90-4. (PMID: 23242137)
Eur J Neurosci. 2006 Sep;24(6):1687-94. (PMID: 17004932)
Front Cell Neurosci. 2013 Mar 05;7:19. (PMID: 23467310)
J Neurosurg. 1997 Jul;87(1):73-8. (PMID: 9202268)
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4146-51. (PMID: 22315426)
Neurology. 2011 Sep 27;77(13):1287-94. (PMID: 21917775)
Arch Pediatr Adolesc Med. 2005 Feb;159(2):151-7. (PMID: 15699309)
J Biol Chem. 2011 Jan 7;286(1):787-96. (PMID: 20978131)
Curr Pharm Des. 2022;28(12):948-968. (PMID: 34218774)
Neurol Clin. 2007 Feb;25(1):71-87. (PMID: 17324721)
Curr Pharm Des. 2022;28(16):1304-1320. (PMID: 35418280)
Brain Res. 1999 Jul 24;835(2):125-36. (PMID: 10415367)
Neuro Oncol. 2016 Oct 1;18(suppl_5):v1-v75. (PMID: 28475809)
Brain Res. 2017 Feb 1;1656:27-39. (PMID: 26778174)
J Biol Chem. 2017 Jun 2;292(22):9432-9438. (PMID: 28341740)
Hippocampus. 2014 Aug;24(8):1030-8. (PMID: 24753100)
Front Neurol. 2019 Feb 05;10:59. (PMID: 30804878)
Biochem Soc Trans. 2013 Feb 1;41(1):241-4. (PMID: 23356290)
Nat Rev Neurosci. 2010 Apr;11(4):227-38. (PMID: 20300101)
J Physiol. 2014 Aug 1;592(15):3201-14. (PMID: 24879866)
Brain Res Rev. 2010 May;63(1-2):212-21. (PMID: 19883685)
Trends Cell Biol. 2009 Feb;19(2):43-51. (PMID: 19144520)
FASEB J. 2010 Jun;24(6):2104-15. (PMID: 20124437)
Proc Natl Acad Sci U S A. 1976 Oct;73(10):3544-8. (PMID: 185619)
Science. 1999 Jan 1;283(5398):74-7. (PMID: 9872744)
Trends Pharmacol Sci. 1991 Dec;12(12):456-61. (PMID: 1792689)
J Neurosci. 1987 Feb;7(2):357-68. (PMID: 2880937)
Neuroscience. 2016 Dec 17;339:587-598. (PMID: 27771530)
Neurochem Res. 2021 Jul;46(7):1618-1626. (PMID: 33900517)
Immunity. 2018 May 15;48(5):979-991.e8. (PMID: 29752066)
Neuron. 2013 Mar 20;77(6):1039-46. (PMID: 23522040)
Neurobiol Dis. 2013 Feb;50:171-8. (PMID: 23103417)
J Neurochem. 2007 Mar;100(6):1431-48. (PMID: 17241126)
J Integr Neurosci. 2022 Jan 28;21(1):42. (PMID: 35164478)
Front Cell Neurosci. 2020 Feb 11;14:20. (PMID: 32116564)
Mol Pharmacol. 2008 Jan;73(1):170-7. (PMID: 17942749)
Exp Neurol. 2013 Jun;244:4-10. (PMID: 21925173)
Science. 2008 Feb 29;319(5867):1244-7. (PMID: 18309083)
Neuromolecular Med. 2019 Mar;21(1):42-53. (PMID: 30644041)
Front Cell Neurosci. 2019 Feb 26;13:63. (PMID: 30863284)
Neural Plast. 2018 Jun 19;2018:7692182. (PMID: 30018633)
Oncol Rep. 2014 Feb;31(2):679-86. (PMID: 24297570)
Stroke. 2012 Sep;43(9):2476-82. (PMID: 22811450)
Br J Pharmacol. 1979 May;66(1):108P. (PMID: 454903)
J Rheumatol. 2005 May;32(5):853-8. (PMID: 15868621)
Glia. 2000 Jan 1;29(1):70-80. (PMID: 10594924)
Neurochem Res. 1995 Apr;20(4):413-20. (PMID: 7651578)
Trends Neurosci. 2006 Jun;29(6):323-9. (PMID: 16697057)
J Neurochem. 1995 Feb;64(2):583-91. (PMID: 7830051)
EMBO J. 2001 May 1;20(9):2152-9. (PMID: 11331581)
Braz J Psychiatry. 2013;35 Suppl 2:S92-100. (PMID: 24271231)
J Neurosci Res. 2018 Aug;96(8):1406-1411. (PMID: 29761540)
Neurosci Biobehav Rev. 1992 Spring;16(1):13-24. (PMID: 1553102)
J Neurosci. 2005 Mar 2;25(9):2192-203. (PMID: 15745945)
Biomed Pharmacother. 2022 Jun 16;153:113305. (PMID: 35717779)
Neurosci Lett. 2002 Aug 30;329(2):181-4. (PMID: 12165407)
Clin Rheumatol. 2007 Aug;26(8):1240-4. (PMID: 17149536)
Nat Cell Biol. 2012 Jun 03;14(7):677-85. (PMID: 22660413)
Neuron. 2014 Mar 5;81(5):1009-1023. (PMID: 24607225)
Cell Calcium. 2013 Dec;54(6):387-94. (PMID: 24138901)
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):777-81. (PMID: 8290599)
Pharmacol Rev. 2018 Oct;70(4):836-878. (PMID: 30275042)
Environ Sci Pollut Res Int. 2022 Jul;29(31):46527-46550. (PMID: 35507224)
Neurobiol Aging. 2012 Aug;33(8):1545-55. (PMID: 21741125)
Int J Mol Med. 2008 Jan;21(1):63-7. (PMID: 18097617)
Front Cell Neurosci. 2020 Aug 21;14:256. (PMID: 32973453)
Neurology. 2009 Jul 7;73(1):39-45. (PMID: 19564582)
Int J Mol Sci. 2021 Nov 23;22(23):. (PMID: 34884440)
Cell Metab. 2014 Jun 3;19(6):1042-9. (PMID: 24814483)
J Biol Chem. 2000 Sep 29;275(39):29955-9. (PMID: 10893407)
Philos Trans R Soc Lond B Biol Sci. 1999 Feb 28;354(1381):403-9. (PMID: 10212490)
Cell. 2020 Jul 23;182(2):265-267. (PMID: 32707091)
Expert Rev Neurother. 2019 May;19(5):359-374. (PMID: 30884983)
Nat Med. 2004 Jul;10 Suppl:S2-9. (PMID: 15272266)
Biology (Basel). 2022 Jan 17;11(1):. (PMID: 35053145)
Nat Rev Neurosci. 2009 Jan;10(1):9-22. (PMID: 19096367)
Curr Neuropharmacol. 2018;16(5):519-532. (PMID: 28847296)
J Biol Chem. 2013 May 31;288(22):15699-711. (PMID: 23592792)
Neurologist. 2007 Jan;13(1):12-9. (PMID: 17215723)
Molecules. 2022 May 17;27(10):. (PMID: 35630670)
Brain. 2018 Jul 1;141(7):1917-1933. (PMID: 29850777)
J Cell Biol. 2010 Apr 19;189(2):223-32. (PMID: 20404108)
Molecules. 2022 Jun 13;27(12):. (PMID: 35744922)
Dev Cell. 2018 Oct 8;47(1):38-52.e6. (PMID: 30300589)
Molecules. 2021 Dec 30;27(1):. (PMID: 35011465)
J Neurosci. 2008 Jan 2;28(1):264-78. (PMID: 18171944)
Front Neurol. 2017 Apr 10;8:138. (PMID: 28443061)
Cereb Cortex. 2008 Dec;18(12):2789-95. (PMID: 18372288)
Neurosci Biobehav Rev. 1992 Spring;16(1):107-13. (PMID: 1553101)
J Biol Chem. 2008 Nov 14;283(46):31884-97. (PMID: 18755690)
PLoS Biol. 2012;10(12):e1001450. (PMID: 23271954)
FASEB J. 2019 Apr;33(4):4703-4715. (PMID: 30592632)
Glia. 2012 Aug;60(8):1251-7. (PMID: 22378298)
Annu Rev Neurosci. 2008;31:535-61. (PMID: 18558866)
Glia. 2010 Feb;58(3):344-66. (PMID: 19780201)
Prog Neurobiol. 2015 Apr;127-128:1-22. (PMID: 25802011)
ASN Neuro. 2012 Apr 05;4(3):. (PMID: 22339481)
J Cell Biol. 2013 Feb 18;200(4):373-83. (PMID: 23420871)
Neuroscience. 2000;100(1):155-70. (PMID: 10996466)
J Neurochem. 1996 Nov;67(5):2188-99. (PMID: 8863530)
Pharmacol Rev. 2002 Jun;54(2):247-64. (PMID: 12037141)
Nature. 1998 Dec 17;396(6712):683-7. (PMID: 9872317)
J Biol Chem. 2004 Jul 9;279(28):29085-91. (PMID: 15126507)
Lancet Neurol. 2015 Apr;14(4):388-405. (PMID: 25792098)
Oxid Med Cell Longev. 2020 May 27;2020:6571484. (PMID: 32566093)
Exp Neurol. 2016 Jan;275 Pt 3:305-315. (PMID: 25828533)
J Neurosci. 2008 Mar 26;28(13):3264-76. (PMID: 18367594)
J Neurosci. 2008 Jan 16;28(3):732-6. (PMID: 18199772)
Neuron. 2011 Jul 14;71(1):35-48. (PMID: 21745636)
Cell. 2011 Mar 4;144(5):810-23. (PMID: 21376239)
Curr Opin Rheumatol. 2005 Jan;17(1):41-8. (PMID: 15604903)
Cells. 2020 Sep 27;9(10):. (PMID: 32992620)
Iran J Basic Med Sci. 2018 Aug;21(8):832-841. (PMID: 30186571)
Cancer Med. 2016 Oct;5(10):2886-2898. (PMID: 27600331)
Int J Environ Res Public Health. 2020 Apr 21;17(8):. (PMID: 32326314)
Antibiotics (Basel). 2021 Sep 06;10(9):. (PMID: 34572660)
Glia. 2017 Apr;65(4):670-682. (PMID: 28168742)
J Neurocytol. 2002 Mar-Jun;31(3-5):299-316. (PMID: 12815249)
Neuroscientist. 2005 Oct;11(5):400-7. (PMID: 16151042)
Neurochem Res. 1985 Oct;10(10):1335-41. (PMID: 4069308)
J Cell Biol. 2013 Feb 18;200(4):367-71. (PMID: 23420870)
Curr Med Chem. 2022 Apr 08;:. (PMID: 35400321)
Mol Autism. 2011 Aug 02;2:13. (PMID: 21810230)
Neurochem Int. 2011 Aug;59(2):259-71. (PMID: 21672581)
Behav Brain Funct. 2019 May 7;15(1):9. (PMID: 31064381)
Adv Pharmacol. 2015;73:223-64. (PMID: 25637443)
FASEB J. 1999 Mar;13(3):533-43. (PMID: 10064620)
Front Cell Neurosci. 2015 Apr 21;9:151. (PMID: 25954157)
Molecules. 2021 Dec 04;26(23):. (PMID: 34885950)
Nature. 2012 Apr 29;485(7399):517-21. (PMID: 22622581)
Glia. 2020 May;68(5):1065-1080. (PMID: 31833596)
Crit Rev Oncol Hematol. 2016 Jan;97:15-21. (PMID: 26558689)
Biochim Biophys Acta. 2013 Nov;1834(11):2454-61. (PMID: 23603790)
Psychopharmacology (Berl). 1991;103(2):143-9. (PMID: 2027916)
Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86. (PMID: 30445539)
Acta Neurochir Suppl. 2016;121:355-60. (PMID: 26463974)
Neuron. 2014 Aug 20;83(4):894-905. (PMID: 25088363)
Physiol Rev. 2013 Oct;93(4):1543-62. (PMID: 24137016)
Neuron. 2015 Sep 23;87(6):1215-1233. (PMID: 26402605)
J Clin Med. 2020 Apr 19;9(4):. (PMID: 32325895)
Neurobiol Dis. 2011 Sep;43(3):678-89. (PMID: 21679768)
Dev Neurosci. 1995;17(4):203-11. (PMID: 8575339)
Neurotox Res. 2020 Mar;37(3):491-507. (PMID: 31823227)
Proc Natl Acad Sci U S A. 2017 May 2;114(18):E3689-E3698. (PMID: 28416698)
J Biol Chem. 2013 Sep 27;288(39):28058-67. (PMID: 23926109)
Front Physiol. 2012 May 28;3:145. (PMID: 22654762)
Mayo Clin Proc. 2017 Mar;92(3):467-479. (PMID: 28259232)
Semin Neurol. 2012 Jul;32(3):187-95. (PMID: 23117943)
Adv Pharmacol. 2015;73:203-22. (PMID: 25637442)
J Neurosci. 2012 Apr 11;32(15):5017-23. (PMID: 22496548)
Materials (Basel). 2022 Jan 21;15(3):. (PMID: 35160749)
Glia. 2017 Mar;65(3):447-459. (PMID: 27896839)
Acta Neurol Belg. 2009 Jun;109(2):100-13. (PMID: 19681441)
Mol Ther. 2013 Dec;21(12):2148-59. (PMID: 24008656)
Psychiatry Investig. 2010 Jun;7(2):122-7. (PMID: 20577621)
J Immunol. 2005 Aug 15;175(4):2237-43. (PMID: 16081791)
Cell Death Dis. 2016 Sep 29;7(9):e2386. (PMID: 27685630)
Neurology. 2016 Mar 1;86(9):800-7. (PMID: 26843559)
Molecules. 2022 Mar 06;27(5):. (PMID: 35268815)
Neuron. 2014 Jan 22;81(2):229-48. (PMID: 24462092)
Nat Rev Mol Cell Biol. 2022 May;23(5):369-382. (PMID: 35260831)
Cell. 2009 Oct 16;139(2):393-404. (PMID: 19837038)
Cell Rep. 2018 Jan 2;22(1):36-43. (PMID: 29298431)
J Neurosci. 2004 Jul 21;24(29):6457-65. (PMID: 15269255)
Exp Neurol. 2013 Sep;247:595-604. (PMID: 23454608)
Neurochem Int. 2010 Nov;57(4):411-20. (PMID: 20380860)
J Neurosci Res. 2005 Aug 1;81(3):374-89. (PMID: 15959904)
Bioengineering (Basel). 2022 Jul 25;9(8):. (PMID: 35892749)
Glia. 2005 Jun;50(4):427-434. (PMID: 15846805)
Glia. 2013 Jul;61(7):1003-17. (PMID: 23625857)
Cell. 2019 May 30;177(6):1522-1535.e14. (PMID: 31130380)
Biochem Soc Trans. 2014 Oct;42(5):1291-301. (PMID: 25233406)
Curr Protoc Neurosci. 2011 Jan;Chapter 9:Unit9.35. (PMID: 21207367)
Curr Neuropharmacol. 2020;18(7):552-562. (PMID: 31969104)
Nature. 2010 Nov 11;468(7321):244-52. (PMID: 21068833)
Biomed Pharmacother. 2022 Jun;150:113041. (PMID: 35658211)
Science. 2006 Jun 2;312(5778):1389-92. (PMID: 16741123)
J Immunol. 2005 Jun 1;174(11):7268-77. (PMID: 15905573)
Ther Adv Neurol Disord. 2018 Jan 15;11:1756285617746640. (PMID: 29403542)
CNS Neurol Disord Drug Targets. 2022 Apr 30;:. (PMID: 35507780)
EMBO J. 2009 Apr 22;28(8):1043-54. (PMID: 19300439)
Ann Neurol. 1993 May;33(5):502-6. (PMID: 7684583)
Drug Discov Today Dis Models. 2008;5(1):13-18. (PMID: 19343094)
J Neurosci. 1992 Feb;12(2):440-53. (PMID: 1531498)
Brain Behav Immun. 2015 Feb;44:100-5. (PMID: 25218900)
Medicine (Baltimore). 1969 May;48(3):173-215. (PMID: 5769741)
J Mol Neurosci. 2014 May;53(1):87-95. (PMID: 24352712)
Neurobiol Dis. 2016 Jan;85:262-274. (PMID: 25766679)
Cell. 2016 Feb 11;164(4):603-15. (PMID: 26871627)
Brain Res. 2000 Jun 9;867(1-2):173-9. (PMID: 10837811)
Mediators Inflamm. 2015;2015:831059. (PMID: 26604433)
Trends Neurosci. 2006 Oct;29(10):547-53. (PMID: 16938356)
ACS Chem Neurosci. 2021 Nov 17;12(22):4319-4335. (PMID: 34747594)
Brain Behav Immun. 2017 Oct;65:274-283. (PMID: 28546058)
Nature. 1988 Sep 1;335(6185):76-9. (PMID: 2842688)
Front Bioeng Biotechnol. 2022 Apr 06;10:874742. (PMID: 35464722)
Neurology. 2003 Sep 9;61(5):623-30. (PMID: 12963752)
Sci Rep. 2015 Jan 21;5:7912. (PMID: 25604482)
Curr Biol. 2020 Jan 20;30(2):276-291.e9. (PMID: 31928877)
Lancet. 1958 Sep 20;2(7047):629-31. (PMID: 13588955)
Nature. 2012 Jul 26;487(7408):443-8. (PMID: 22801498)
Glia. 2015 May;63(5):846-59. (PMID: 25628003)
Am J Pathol. 2013 Aug;183(2):516-25. (PMID: 23746653)
J Neurosci. 2002 Apr 1;22(7):2443-50. (PMID: 11923408)
Mol Cell Neurosci. 2000 Oct;16(4):296-312. (PMID: 11085869)
Glia. 2012 Aug;60(8):1227-33. (PMID: 22389222)
Science. 2013 Jan 11;339(6116):197-200. (PMID: 23307741)
Neuron. 2014 Feb 19;81(4):728-39. (PMID: 24559669)
Glia. 1993 May;8(1):42-50. (PMID: 8509163)
Curr Opin Cell Biol. 2009 Aug;21(4):575-81. (PMID: 19442504)
Brain Res. 1992 Nov 6;595(1):50-6. (PMID: 1467958)
Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(7):235-50. (PMID: 25169670)
Neuroscience. 2021 Feb 21;456:71-84. (PMID: 32224231)
J Neurol. 2005 Jun;252(6):633-41. (PMID: 15806339)
Psychopharmacology (Berl). 1994 Oct;116(2):135-42. (PMID: 7862942)
Nat Med. 2012 Jun;18(6):883-91. (PMID: 22635005)
J Mol Neurosci. 2015 Jul;56(3):644-51. (PMID: 25691153)
J Extracell Vesicles. 2013 Feb 15;2:. (PMID: 24009890)
Mult Scler Int. 2014;2014:285245. (PMID: 25374694)
Cytokine. 2022 Sep;157:155962. (PMID: 35853395)
Ann Neurol. 1982 Feb;11(2):136-41. (PMID: 7041788)
Glia. 2012 Aug;60(8):1215-26. (PMID: 22592998)
Traffic. 2009 Oct;10(10):1528-42. (PMID: 19682328)
Front Physiol. 2012 May 03;3:124. (PMID: 22563321)
Neurology. 2004 Sep 14;63(5):874-8. (PMID: 15365139)
Neurobiol Dis. 2016 Sep;93:226-42. (PMID: 27145117)
Neuroscience. 2018 Feb 10;371:445-454. (PMID: 29292076)
Brain Sci. 2020 Apr 01;10(4):. (PMID: 32244776)
J Neurosci Res. 2017 Oct;95(10):2080-2085. (PMID: 28316070)
Trends Neurosci. 2009 Aug;32(8):421-31. (PMID: 19615761)
Cell. 2013 Dec 19;155(7):1451-63. (PMID: 24315484)
Neuron. 2016 Mar 16;89(6):1157-1172. (PMID: 26985723)
Nat Rev Immunol. 2011 Oct 25;11(11):775-87. (PMID: 22025055)
Curr Opin Neurobiol. 2014 Aug;27:75-81. (PMID: 24694749)
BMC Syst Biol. 2011 Oct 13;5:162. (PMID: 21995951)
Front Physiol. 2012 Apr 30;3:119. (PMID: 22557979)
J Biol Chem. 2012 May 11;287(20):16820-34. (PMID: 22437826)
Brain. 2008 Apr;131(Pt 4):1113-22. (PMID: 18299297)
Br J Pharmacol. 2006 Jan;147 Suppl 1:S120-6. (PMID: 16402095)
Front Cell Neurosci. 2013 Oct 30;7:182. (PMID: 24194697)
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):11832-11837. (PMID: 30373833)
Neuron. 2012 Oct 4;76(1):116-29. (PMID: 23040810)
Adv Exp Med Biol. 2016;949:1-24. (PMID: 27714682)
Antibiotics (Basel). 2022 May 16;11(5):. (PMID: 35625311)
Folia Neuropathol. 2006;44(2):140-3. (PMID: 16823697)
Nat Cell Biol. 2012 Oct;14(10):1036-45. (PMID: 22983114)
Curr Gene Ther. 2021;21(3):216-229. (PMID: 33655857)
Biomed Pharmacother. 2022 Aug;152:113217. (PMID: 35679719)
Trends Neurosci. 1999 May;22(5):208-15. (PMID: 10322493)
J Neurochem. 2012 Apr;121(1):4-27. (PMID: 22251135)
Genomics Proteomics Bioinformatics. 2016 Jun;14(3):155-165. (PMID: 27245308)
Circ Res. 2007 Feb 2;100(2):155-7. (PMID: 17272817)
J Clin Neuromuscul Dis. 2007 Sep;9(1):265-76. (PMID: 17989592)
Exp Neurol. 2000 May;163(1):157-64. (PMID: 10785454)
Front Cell Neurosci. 2020 Jul 29;14:209. (PMID: 32848613)
Semin Arthritis Rheum. 2006 Oct;36(2):88-98. (PMID: 17023257)
J Neurosci. 2019 Mar 27;39(13):2542-2561. (PMID: 30683682)
Neuron. 2014 Jun 18;82(6):1263-70. (PMID: 24945771)
Neuron. 2020 Mar 18;105(6):1036-1047.e5. (PMID: 31954621)
Cold Spring Harb Symp Quant Biol. 1990;55:29-40. (PMID: 1966765)
Pharmacol Rev. 2008 Sep;60(3):243-60. (PMID: 18790874)
Brain. 2015 Jun;138(Pt 6):1484-91. (PMID: 25808373)
Traffic. 2011 Dec;12(12):1659-68. (PMID: 21645191)
Front Neurol. 2019 Jan 04;9:1139. (PMID: 30662428)
Adv Exp Med Biol. 2012;970:307-31. (PMID: 22351062)
Br J Pharmacol. 1992 Mar;105(3):720-6. (PMID: 1385752)
Curr Opin Neurol. 2004 Oct;17(5):587-98. (PMID: 15367863)
Curr Pharm Des. 2018;24(22):2597-2608. (PMID: 30147009)
PLoS One. 2012;7(3):e33693. (PMID: 22470460)
Cell Death Dis. 2012 Aug 30;3:e381. (PMID: 22932723)
JAMA Oncol. 2016 Nov 01;2(11):1460-1469. (PMID: 27310651)
Nat Neurosci. 2015 Nov;18(11):1539-1545. (PMID: 26505565)
Neurobiol Aging. 2004 May-Jun;25(5):663-74. (PMID: 15172746)
J Neurosci. 2008 Nov 26;28(48):12788-97. (PMID: 19036971)
Entry Date(s):
Date Created: 20220901 Date Completed: 20220907 Latest Revision: 20220907
Update Code:
20240105
PubMed Central ID:
PMC9423989
DOI:
10.1155/2022/3201644
PMID:
36046684
Czasopismo naukowe
Based on the diverse physiological influence, the impact of glial cells has become much more evident on neurological illnesses, resulting in the origins of many diseases appearing to be more convoluted than previously happened. Since neurological disorders are often random and unknown, hence the construction of animal models is difficult to build, representing a small fraction of people with a gene mutation. As a result, an immediate necessity is grown to work within in vitro techniques for examining these illnesses. As the scientific community recognizes cell-autonomous contributions to a variety of central nervous system illnesses, therapeutic techniques involving stem cells for treating neurological diseases are gaining traction. The use of stem cells derived from a variety of sources is increasingly being used to replace both neuronal and glial tissue. The brain's energy demands necessitate the reliance of neurons on glial cells in order for it to function properly. Furthermore, glial cells have diverse functions in terms of regulating their own metabolic activities, as well as collaborating with neurons via secreted signaling or guidance molecules, forming a complex network of neuron-glial connections in health and sickness. Emerging data reveals that metabolic changes in glial cells can cause morphological and functional changes in conjunction with neuronal dysfunction under disease situations, highlighting the importance of neuron-glia interactions in the pathophysiology of neurological illnesses. In this context, it is required to improve our understanding of disease mechanisms and create potential novel therapeutics. According to research, synaptic malfunction is one of the features of various mental diseases, and glial cells are acting as key ingredients not only in synapse formation, growth, and plasticity but also in neuroinflammation and synaptic homeostasis which creates critical physiological capacity in the focused sensory system. The goal of this review article is to elaborate state-of-the-art information on a few glial cell types situated in the central nervous system (CNS) and highlight their role in the onset and progression of neurological disorders.
Competing Interests: The authors declare no conflict of interest.
(Copyright © 2022 Md. Mominur Rahman et al.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies